Galectin-14 antibody
Principal name
Galectin-14 antibody
Alternative names for Galectin-14 antibody
LGALS14, PPL13, Placental protein 13-like, Charcot-Leyden crystal protein 2, CLC2, Galectin14
SwissProt ID
Q8TCE9 (Human)
Gene ID
56891 (LGALS14)
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of Galectin-14 antibody
LGALS14, also known as Galectin14, belongs to the galectin family of carbohydrate binding proteins. This protein is expressed intracellularly in placenta and eosinophils and is released by eosinophils following allergen stimulation. It may be involved in the development of allergic inflammation. Recombinant human LGALS14 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography.
General readings
Athanasiadou S., et al. (2008), Vet Res., 39(6):58.
Young AR., et al. (2009). Glycoconj J., 26(4):423-32.
Human Stomach; WB Suggested Anti-LGALS14 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human Stomach; LGALS14 antibody - N-terminal region (ARP42549_P050) in Human Stomach cells using Western Blot
Recombinant human LGALS14, 1-139aa, His-tagged
Western Blot: LGALS14 Antibody [NBP1-57683] - This Anti-LGALS14 antibody was used in Western Blot of Fetal Stomach tissue lysate at a concentration of 1ug/ml.
Detection of LGALS14 in Fetal Stomach using anti-LGALS14 antibody (GTX46996) at 1 µg/mL.
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP304625 | Galectin-14 (transcript variant 1) |
||||
| Recombinant protein of human lectin, galactoside-binding, soluble, 14 (LGALS14), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY412669 | LGALS14 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
